The Patent Finder

Celgene Avilomics Research, Inc.

Also on record
Records under this name other than patents Celgene Avilomics Research, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Celgene Avilomics Research, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,609,6792,4-Diaminopyrimidines Useful as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 8,710,2222,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 9,212,181Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 9,296,737Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 9,987,276Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 10,010,5482,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 10,596,1722,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 10,828,300Substituted 2,4-Diaminopyrimidines as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 11,351,1682,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
US 8,338,4392,4-Disubstituted Pyrimidines Useful as Kinase Inhibitors
In force
 · High confidence
In forceHigh confidence
10 of 112 records shown.
Pro members see all 112.
Pro members: see all 112 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited